Loss of NLRX1 Exacerbates Neural Tissue Damage and NF-κB Signaling following Brain Injury

• Published in: The Journal of immunology (1950) Vol. 199; no. 10; pp. 3547 - 3558
• Main Authors: Theus, Michelle H, Brickler, Thomas, Meza, Armand L, Coutermarsh-Ott, Sheryl, Hazy, Amanda, Gris, Denis, Allen, Irving C
• Format: Journal Article
• Language: English
• Published: United States American Association of Immunologists 15.11.2017
• Subjects: Aneurysm; Animal models; Animals; Apoptosis; Brain Injuries - genetics; Brain Injuries - immunology; Cell Line, Tumor; Cellular Microenvironment; Cerebral Cortex - immunology; Cerebral Cortex - pathology; Cortex; Excitotoxicity; Gene Expression Regulation; Humans; Hypoxia; Hypoxia - genetics; Hypoxia - immunology; Immune system; Inflammation; Intracranial Aneurysm - genetics; Intracranial Aneurysm - immunology; Ischemia; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Microglia - immunology; Mitochondrial Proteins - genetics; Mitochondrial Proteins - metabolism; NF-kappa B - metabolism; NF-κB protein; Pattern recognition receptors; Retrospective Studies; Signal Transduction; Traumatic brain injury
• ISSN: 0022-1767; 1550-6606; 1550-6606
• DOI: 10.4049/jimmunol.1700251

Traumatic and nontraumatic brain injury results from severe disruptions in the cellular microenvironment leading to massive loss of neuronal populations and increased neuroinflammation. The progressive cascade of secondary events, including ischemia, inflammation, excitotoxicity, and free-radical release, contribute to neural tissue damage. NLRX1 is a member of the NLR family of pattern recognition receptors and is a potent negative regulator of several pathways that significantly modulate many of these events. Thus, we hypothesized that NLRX1 limits immune system signaling in the brain following trauma. To evaluate this hypothesis, we used Nlrx1−/− mice in a controlled cortical impact (CCI) injury murine model of traumatic brain injury (TBI). In this article, we show that Nlrx1−/− mice exhibited significantly larger brain lesions and increased motor deficits following CCI injury. Mechanistically, our data indicate that the NF-κB signaling cascade is significantly upregulated in Nlrx1−/− animals. This upregulation is associated with increased microglia and macrophage populations in the cortical lesion. Using a mouse neuroblastoma cell line (N2A), we also found that NLRX1 significantly reduced apoptosis under hypoxic conditions. In human patients, we identify 15 NLRs that are significantly dysregulated, including significant downregulation of NLRX1 in brain injury following aneurysm. We further demonstrate a concurrent increase in NF-κB signaling that is correlated with aneurysm severity in these human subjects. Together, our data extend the function of NLRX1 beyond its currently characterized role in host–pathogen defense and identify this highly novel NLR as a significant modulator of brain injury progression.